Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
LRRC8B	23507	broad.mit.edu	37	1	90048973	90048973	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr1:90048973A>G	ENST00000330947.2	+	5	1124	c.764A>G	c.(763-765)tAt>tGt	p.Y255C	RP5-1007M22.2_ENST00000443562.1_RNA|LRRC8B_ENST00000358200.4_Missense_Mutation_p.Y255C|LRRC8B_ENST00000439853.1_Missense_Mutation_p.Y255C	NM_001134476.1	NP_001127948.1	Q6P9F7	LRC8B_HUMAN	leucine rich repeat containing 8 family, member B	255		NA				integral to membrane				breast(1)|central_nervous_system(1)|endometrium(6)|kidney(5)|large_intestine(2)|lung(5)|ovary(2)|prostate(2)|skin(1)|urinary_tract(1)	26		all_lung(203;0.17)		all cancers(265;0.00515)|Epithelial(280;0.0241)		GACATCATTTATAGAGTATAT	0.383	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													92	90	91	NA		NA	NA	1		NA											NA				90048973		2203	4300	6503	SO:0001583	missense			ENSG00000197147	HGNC:30692	NM_015350	Approved	uc001dni.3	NA	D3DT28|Q6UY21|Q8N106|Q92627	ENST00000330947.2	37	CCDS724.1	.	.	.	.	.	.	.	.	.	.	A	16.83	3.230578	0.58777	.	.	ENSG00000197147	ENST00000330947;ENST00000358200;ENST00000439853	T;T;T	0.52754	0.65;0.65;0.65	5.3	5.3	0.74995	.	0.000000	0.64402	D	0.000002	T	0.59582	0.2204	M	0.74647	2.275	0.58432	D	0.999992	D	0.76494	0.999	P	0.62813	0.907	T	0.66444	-0.5922	10	0.87932	D	0	.	15.5356	0.76001	1.0:0.0:0.0:0.0	.	255	Q6P9F7	LRC8B_HUMAN	C	255	ENSP00000332674:Y255C;ENSP00000350933:Y255C;ENSP00000400704:Y255C	ENSP00000332674:Y255C	Y	+	2	0	LRRC8B	89821561	1.000000	0.71417	0.994000	0.49952	0.992000	0.81027	9.273000	0.95719	2.125000	0.65367	0.533000	0.62120	TAT	LRRC8B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000028008.1	141.325449	KEEP		+	141.336219	0.4875	39	41	---	---	---	---	1	0.9987551	5	10	0	143	47	49	0	143	2	0	0	0	0	0	143	47	49	0	143	2	TP
TTF2	8458	broad.mit.edu	37	1	117618058	117618058	+	Silent	SNP	G	G	A			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr1:117618058G>A	ENST00000369466.3	+	5	896	c.852G>A	c.(850-852)gaG>gaA	p.E284E		NM_003594.3	NP_003585.3	Q9UNY4	TTF2_HUMAN	transcription termination factor, RNA polymerase II	284		NA			mRNA processing|regulation of transcription, DNA-dependent|RNA splicing|termination of RNA polymerase II transcription	cytoplasm|spliceosomal complex|transcription elongation factor complex	ATP binding|ATP-dependent helicase activity|DNA binding|DNA-dependent ATPase activity|protein binding|zinc ion binding			NS(1)|autonomic_ganglia(1)|breast(1)|cervix(2)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(7)|liver(1)|lung(24)|ovary(1)|prostate(2)|skin(2)|urinary_tract(2)	50	Lung SC(450;0.225)	all_cancers(81;4.23e-06)|all_epithelial(167;3.65e-07)|all_lung(203;2.81e-06)|Lung NSC(69;1.98e-05)		Lung(183;0.0553)|Colorectal(144;0.179)|LUSC - Lung squamous cell carcinoma(189;0.19)		TCAACAAGGAGTACACGAACT	0.522	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													76	83	80	NA		NA	NA	1		NA											NA				117618058		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000116830	HGNC:12398		Approved	uc001egy.3	NA	A8K4Q2|O75921|Q5T2K7|Q5VVU8|Q8N6I8	ENST00000369466.3	37	CCDS892.1																																																																																			TTF2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000033277.2	139.310755	KEEP		+	158.030002	0.221374	58	204	---	---	---	---	1	0.4874382	3	4	0	182	73	255	0	182	2	0	0	0	0	0	182	73	255	0	182	2	TP
LPIN1	23175	broad.mit.edu	37	2	11943091	11943091	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr2:11943091G>A	ENST00000256720.2	+	14	1930	c.1837G>A	c.(1837-1839)Gca>Aca	p.A613T	LPIN1_ENST00000396099.1_Missense_Mutation_p.A655T|LPIN1_ENST00000449576.2_Missense_Mutation_p.A698T|LPIN1_ENST00000396097.1_Missense_Mutation_p.A343T|LPIN1_ENST00000404113.2_Missense_Mutation_p.A114T|LPIN1_ENST00000425416.2_Missense_Mutation_p.A619T	NM_145693.2	NP_663731.1	Q14693	LPIN1_HUMAN	lipin 1	613		NA			fatty acid catabolic process|transcription, DNA-dependent|triglyceride biosynthetic process|triglyceride mobilization	cytosol|endoplasmic reticulum membrane	phosphatidate phosphatase activity			autonomic_ganglia(1)|breast(1)|cervix(1)|endometrium(2)|kidney(5)|large_intestine(15)|liver(1)|lung(10)|ovary(2)|prostate(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(2)	45	all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155)			Epithelial(75;0.11)|OV - Ovarian serous cystadenocarcinoma(76;0.173)		GCCATCAAACGCAGGCCACCT	0.532	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0								G	THR/ALA	0,4406		0,0,2203	177	152	160	NA	1837	-5.7	0	2		160	2,8598	2.2+/-6.3	0,2,4298	no	missense	LPIN1	NM_145693.1	58	0,2,6501	AA,AG,GG	NA	0.0233,0.0,0.0154	benign	613/891	11943091	2,13004	2203	4300	6503	SO:0001583	missense			ENSG00000134324	HGNC:13345	NM_145693	Approved	uc010yjm.3	NA	Q53T25	ENST00000256720.2	37	CCDS1682.1	.	.	.	.	.	.	.	.	.	.	G	0.095	-1.161584	0.01673	0.0	2.33E-4	ENSG00000134324	ENST00000449576;ENST00000396099;ENST00000425416;ENST00000256720;ENST00000396097;ENST00000404113;ENST00000454151	T;T;T;T;T;T;T	0.80480	-1.38;-1.37;-1.37;-1.37;-1.21;-0.37;0.55	4.56	-5.7	0.02421	.	0.613558	0.17891	N	0.158537	T	0.46908	0.1417	N	0.05383	-0.06	0.09310	N	1	B;B;B	0.10296	0.0;0.003;0.0	B;B;B	0.09377	0.001;0.004;0.001	T	0.52124	-0.8617	10	0.07325	T	0.83	-3.7431	1.9602	0.03385	0.2688:0.077:0.3183:0.3358	.	114;698;613	B4DET9;F5GY24;Q14693	.;.;LPIN1_HUMAN	T	698;655;619;613;343;114;140	ENSP00000397908:A698T;ENSP00000379406:A655T;ENSP00000401522:A619T;ENSP00000256720:A613T;ENSP00000379404:A343T;ENSP00000386120:A114T;ENSP00000413714:A140T	ENSP00000256720:A613T	A	+	1	0	LPIN1	11860542	0.000000	0.05858	0.000000	0.03702	0.010000	0.07245	-1.810000	0.01729	-1.160000	0.02804	-2.048000	0.00412	GCA	LPIN1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000239296.3	125.417774	KEEP		+	144.410238	0.214286	54	198	---	---	---	---	1	0.9827433	6	16	0	300	143	437	0	300	2	0	0	0	0	0	300	143	437	0	300	2	TP
MRPS25	64432	broad.mit.edu	37	3	15093843	15093843	+	3'UTR	SNP	G	G	C			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr3:15093843G>C	ENST00000253686.2	-	0	767				MRPS25_ENST00000444840.2_3'UTR|MRPS25_ENST00000449354.2_Intron|MRPS25_ENST00000496484.1_5'Flank	NM_022497.3	NP_071942.1	P82663	RT25_HUMAN	mitochondrial ribosomal protein S25	NA		NA			translation	mitochondrial small ribosomal subunit	protein binding|structural constituent of ribosome			large_intestine(1)|lung(1)	2						AGGATTTCCAGAGTCTCCAGG	0.517	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000131368	HGNC:14511	NM_022497	Approved	uc003bzl.3	NA	Q9H7P5	ENST00000253686.2	37	CCDS2622.1																																																																																			MRPS25-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000252076.2	12.393185	KEEP		-	13.13078	0.266667	4	11	---	---	---	---	1	0.9991538	34	32	0	41	4	11	0	41	2	0	0	0	0	0	41	4	11	0	41	2	TP
SLCO2A1	6578	broad.mit.edu	37	3	133692615	133692615	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr3:133692615G>A	ENST00000310926.4	-	3	562	c.289C>T	c.(289-291)Cgt>Tgt	p.R97C	SLCO2A1_ENST00000478651.1_5'UTR|SLCO2A1_ENST00000493729.1_Missense_Mutation_p.R97C	NM_005630.2	NP_005621.2	Q92959	SO2A1_HUMAN	solute carrier organic anion transporter family, member 2A1	97		NA			sodium-independent organic anion transport	integral to plasma membrane|membrane fraction	prostaglandin transmembrane transporter activity|protein binding			breast(3)|central_nervous_system(1)|cervix(1)|endometrium(3)|large_intestine(5)|lung(10)|ovary(1)|prostate(2)|skin(2)|stomach(2)	30						AGACGTGGACGGTGCACCCGG	0.572	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													91	79	83	NA		NA	NA	3		NA											NA				133692615		2203	4300	6503	SO:0001583	missense			ENSG00000174640	HGNC:10955	NM_005630	Approved	uc003eqa.4	NA	Q86V98|Q8IUN2	ENST00000310926.4	37	CCDS3084.1	.	.	.	.	.	.	.	.	.	.	g	31	5.092072	0.94149	.	.	ENSG00000174640	ENST00000310926;ENST00000493729	T;T	0.55052	0.54;0.54	5.49	5.49	0.81192	Major facilitator superfamily domain, general substrate transporter (1);Major facilitator superfamily domain (1);	0.055982	0.85682	D	0.000000	T	0.80949	0.4722	M	0.94101	3.495	0.42095	D	0.991313	D;D;D	0.89917	1.0;1.0;1.0	D;D;D	0.97110	0.999;1.0;1.0	D	0.86089	0.1549	10	0.87932	D	0	.	19.3794	0.94525	0.0:0.0:1.0:0.0	.	97;97;97	B7Z8J8;E7EU40;Q92959	.;.;SO2A1_HUMAN	C	97	ENSP00000311291:R97C;ENSP00000418893:R97C	ENSP00000311291:R97C	R	-	1	0	SLCO2A1	135175305	1.000000	0.71417	0.999000	0.59377	0.958000	0.62258	7.368000	0.79567	2.553000	0.86117	0.651000	0.88453	CGT	SLCO2A1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000357131.1	79.532004	KEEP		-	81.086554	0.346667	26	49	---	---	---	---	1	0.9909076	5	15	0	31	29	64	0	31	2	0	0	0	0	0	31	29	64	0	31	2	TP
BCHE	590	broad.mit.edu	37	3	165548715	165548715	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr3:165548715G>T	ENST00000264381.3	-	2	273	c.107C>A	c.(106-108)aCa>aAa	p.T36K	BCHE_ENST00000540653.1_Intron	NM_000055.2	NP_000046.1	P06276	CHLE_HUMAN	butyrylcholinesterase	36		NA			choline metabolic process|cocaine metabolic process|synaptic transmission, cholinergic	endoplasmic reticulum lumen|extracellular space|membrane	acetylcholinesterase activity|beta-amyloid binding|carboxylesterase activity|cholinesterase activity|enzyme binding			breast(1)|endometrium(2)|kidney(1)|large_intestine(10)|lung(34)|ovary(4)|pancreas(2)|stomach(1)	55					Ambenonium(DB01122)|Atropine(DB00572)|Bambuterol(DB01408)|Chlorpromazine(DB00477)|Choline(DB00122)|Cinnarizine(DB00568)|Demecarium bromide(DB00944)|Dibucaine(DB00527)|Donepezil(DB00843)|Echothiophate Iodide(DB01057)|Edrophonium(DB01010)|Ethopropazine(DB00392)|Etomidate(DB00292)|Galantamine(DB00674)|Hexafluronium bromide(DB00941)|Isoflurophate(DB00677)|Mefloquine(DB00358)|Mivacurium(DB01226)|Neostigmine(DB01400)|Pancuronium(DB01337)|Pralidoxime(DB00733)|Procainamide(DB01035)|Pyridostigmine(DB00545)|Rivastigmine(DB00989)|Succinylcholine(DB00202)|Terbutaline(DB00871)|Trimethaphan(DB01116)	TCCATTCTTTGTTGCAATTAT	0.408	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													87	80	82	NA		NA	NA	3		NA											NA				165548715		2203	4300	6503	SO:0001583	missense			ENSG00000114200	HGNC:983		Approved	uc003fem.4	NA	A8K7P8	ENST00000264381.3	37	CCDS3198.1	.	.	.	.	.	.	.	.	.	.	G	13.72	2.320194	0.41096	.	.	ENSG00000114200	ENST00000264381	D	0.96365	-3.99	5.81	5.81	0.92471	Carboxylesterase, type B (1);	0.108147	0.64402	D	0.000007	D	0.98937	0.9639	H	0.97682	4.055	0.80722	D	1	D	0.89917	1.0	D	0.80764	0.994	D	0.99331	1.0909	10	0.87932	D	0	.	19.0644	0.93104	0.0:0.0:1.0:0.0	.	36	P06276	CHLE_HUMAN	K	36	ENSP00000264381:T36K	ENSP00000264381:T36K	T	-	2	0	BCHE	167031409	1.000000	0.71417	0.979000	0.43373	0.044000	0.14063	6.109000	0.71528	2.756000	0.94617	0.655000	0.94253	ACA	BCHE-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000350254.1	84.412552	KEEP		-	84.963698	0.402985	27	40	---	---	---	---	1	1	8	25	0	123	28	51	0	123	2	0	0	0	0	0	123	28	51	0	123	2	TP
SEC31A	22872	broad.mit.edu	37	4	83799939	83799939	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr4:83799939C>T	ENST00000432794.1	-	4	509	c.346G>A	c.(346-348)Gcc>Acc	p.A116T	SEC31A_ENST00000443462.2_Missense_Mutation_p.A111T|SEC31A_ENST00000513858.1_Missense_Mutation_p.A116T|SEC31A_ENST00000436790.2_5'UTR|SEC31A_ENST00000509142.1_Missense_Mutation_p.A116T|SEC31A_ENST00000508502.1_Missense_Mutation_p.A116T|SEC31A_ENST00000505984.1_Missense_Mutation_p.A116T|SEC31A_ENST00000505472.1_Missense_Mutation_p.A116T|SEC31A_ENST00000500777.2_Missense_Mutation_p.A116T|SEC31A_ENST00000448323.1_Missense_Mutation_p.A116T|SEC31A_ENST00000395310.2_Missense_Mutation_p.A116T|SEC31A_ENST00000355196.2_Missense_Mutation_p.A116T|SEC31A_ENST00000348405.4_Missense_Mutation_p.A116T|SEC31A_ENST00000326950.5_Missense_Mutation_p.A116T|SEC31A_ENST00000311785.7_Missense_Mutation_p.A116T|SEC31A_ENST00000508479.1_Missense_Mutation_p.A116T			O94979	SC31A_HUMAN	SEC31 homolog A (S. cerevisiae)	116		NA			COPII vesicle coating|post-translational protein modification|protein N-linked glycosylation via asparagine|protein transport|response to calcium ion	COPII vesicle coat|cytosol|endoplasmic reticulum membrane|perinuclear region of cytoplasm	calcium-dependent protein binding		SEC31A/ALK(3)|SEC31A/JAK2(4)	breast(1)	1		Hepatocellular(203;0.114)				TCATTCTGGGCAATCACAACT	0.398	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													105	105	105	NA		NA	NA	4		NA											NA				83799939		2203	4300	6503	SO:0001583	missense			ENSG00000138674	HGNC:17052	NM_016211	Approved	uc003hnh.3	NA	B7ZKZ7|Q17RR5|Q5H9P6|Q5XG74|Q659G7|Q6ZU90|Q7LCX9|Q86TJ0|Q8IZH4|Q9P048|Q9P0A6|Q9UM05|Q9UM06	ENST00000432794.1	37		.	.	.	.	.	.	.	.	.	.	C	23.6	4.440268	0.83993	.	.	ENSG00000138674	ENST00000348405;ENST00000513858;ENST00000395310;ENST00000443462;ENST00000509142;ENST00000432794;ENST00000448323;ENST00000326950;ENST00000311785;ENST00000505472;ENST00000500777;ENST00000508502;ENST00000355196;ENST00000505984;ENST00000508479;ENST00000503058;ENST00000514326;ENST00000513323	T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T	0.62639	1.61;1.61;1.61;1.57;1.61;1.61;1.61;1.61;1.61;1.61;1.61;1.61;1.61;1.61;1.61;0.01;0.14;0.14	5.31	5.31	0.75309	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);	0.162693	0.53938	D	0.000046	T	0.76278	0.3965	L	0.53780	1.695	0.52099	D	0.999949	B;P;P;P;B;B;P;D;P	0.76494	0.434;0.714;0.775;0.897;0.383;0.198;0.729;0.999;0.781	B;B;B;P;B;B;B;D;B	0.87578	0.223;0.113;0.356;0.656;0.155;0.257;0.395;0.998;0.358	T	0.74000	-0.3805	10	0.41790	T	0.15	-12.5777	19.1738	0.93594	0.0:1.0:0.0:0.0	.	111;116;116;116;116;116;116;116;116	B4DIW6;B7ZL00;O94979-5;D6RHZ5;O94979-6;O94979-4;O94979-3;O94979-2;O94979	.;.;.;.;.;.;.;.;SC31A_HUMAN	T	116;116;116;111;116;116;116;116;116;116;116;116;116;116;116;87;116;116	ENSP00000337602:A116T;ENSP00000426886:A116T;ENSP00000378721:A116T;ENSP00000408027:A111T;ENSP00000426569:A116T;ENSP00000407944:A116T;ENSP00000400926:A116T;ENSP00000325087:A116T;ENSP00000309070:A116T;ENSP00000421633:A116T;ENSP00000421464:A116T;ENSP00000424635:A116T;ENSP00000347329:A116T;ENSP00000424451:A116T;ENSP00000425999:A116T;ENSP00000425056:A87T;ENSP00000425555:A116T;ENSP00000426950:A116T	ENSP00000309070:A116T	A	-	1	0	SEC31A	84018963	1.000000	0.71417	1.000000	0.80357	0.989000	0.77384	3.743000	0.55104	2.764000	0.94973	0.655000	0.94253	GCC	SEC31A-203	KNOWN	basic	protein_coding	NA	protein_coding		25.296489	KEEP		-	41.096441	0.137097	17	107	---	---	---	---	1	0.9792958	3	36	1	229	22	133	1	229	2	0	0	0	0	1	229	22	133	1	229	2	TP
MYO10	4651	broad.mit.edu	37	5	16668507	16668507	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr5:16668507C>T	ENST00000513610.1	-	40	6408	c.5954G>A	c.(5953-5955)cGt>cAt	p.R1985H	MYO10_ENST00000505695.1_Missense_Mutation_p.R1324H|MYO10_ENST00000515803.1_Missense_Mutation_p.R1324H|MYO10_ENST00000274203.9_Missense_Mutation_p.R1342H|MYO10_ENST00000427430.2_Missense_Mutation_p.R1342H	NM_012334.2	NP_036466.2	Q9HD67	MYO10_HUMAN	myosin X	1985	FERM.	NA			axon guidance|signal transduction	myosin complex	actin binding|ATP binding|motor activity			NS(1)|breast(3)|central_nervous_system(1)|cervix(1)|endometrium(12)|haematopoietic_and_lymphoid_tissue(1)|kidney(11)|large_intestine(19)|lung(28)|ovary(2)|pancreas(1)|prostate(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	86						TCCCTCTCCACGCTTGTAGAC	0.547	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0								C	HIS/ARG	0,4102		0,0,2051	85	86	86	NA	5954	5.1	1	5		86	1,8445		0,1,4222	no	missense	MYO10	NM_012334.2	29	0,1,6273	TT,TC,CC	NA	0.0118,0.0,0.0080	probably-damaging	1985/2059	16668507	1,12547	2051	4223	6274	SO:0001583	missense				HGNC:7593	NM_012334	Approved	uc003jft.4	NA	A7E2D1|O94893|Q9NYM7|Q9P110|Q9P111|Q9UHF6	ENST00000513610.1	37	CCDS54834.1	.	.	.	.	.	.	.	.	.	.	C	27.1	4.797782	0.90538	0.0	1.18E-4	ENSG00000145555	ENST00000513610;ENST00000515803;ENST00000274203;ENST00000505695;ENST00000427430	D;D;D;D;D	0.88201	-2.26;-2.35;-2.27;-2.35;-2.27	5.14	5.14	0.70334	FERM domain (1);	.	.	.	.	D	0.94634	0.8270	M	0.82323	2.585	0.80722	D	1	D;D;D	0.89917	1.0;1.0;1.0	D;D;D	0.85130	0.997;0.996;0.997	D	0.93433	0.6787	9	0.30078	T	0.28	.	18.621	0.91321	0.0:1.0:0.0:0.0	.	864;1625;1985	B4DIJ5;Q69YP8;Q9HD67	.;.;MYO10_HUMAN	H	1985;1324;1342;1324;1342	ENSP00000421280:R1985H;ENSP00000425051:R1324H;ENSP00000274203:R1342H;ENSP00000421170:R1324H;ENSP00000391106:R1342H	ENSP00000274203:R1342H	R	-	2	0	MYO10	16721507	1.000000	0.71417	1.000000	0.80357	0.535000	0.34838	7.773000	0.85462	2.390000	0.81377	0.591000	0.81541	CGT	MYO10-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000366167.1	156.644275	KEEP		-	162.92119	0.304348	56	128	---	---	---	---	1	1	62	108	0	146	66	145	0	146	2	0	0	0	0	0	146	66	145	0	146	2	TP
CDH9	1007	broad.mit.edu	37	5	26885965	26885965	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr5:26885965G>A	ENST00000231021.4	-	11	1812	c.1640C>T	c.(1639-1641)gCa>gTa	p.A547V		NM_016279.3	NP_057363.3	Q9ULB4	CADH9_HUMAN	cadherin 9, type 2 (T1-cadherin)	547	Cadherin 5.	NA			adherens junction organization|cell junction assembly|homophilic cell adhesion	integral to membrane|plasma membrane	calcium ion binding			breast(6)|endometrium(7)|haematopoietic_and_lymphoid_tissue(2)|large_intestine(25)|lung(80)|ovary(5)|prostate(4)|skin(5)|upper_aerodigestive_tract(2)|urinary_tract(1)	137						CATGATTCCTGCTGTATTATC	0.318	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Melanoma(8;187 585 15745 40864 52829)					NA		NA				0													55	57	57	NA		NA	NA	5		NA											NA				26885965		2203	4300	6503	SO:0001583	missense			ENSG00000113100	HGNC:1768	NM_016279	Approved	uc003jgs.1	NA	Q3B7I5	ENST00000231021.4	37	CCDS3893.1	.	.	.	.	.	.	.	.	.	.	G	25.2	4.614655	0.87359	.	.	ENSG00000113100	ENST00000231021	T	0.20200	2.09	5.79	5.79	0.91817	Cadherin (4);Cadherin-like (1);	0.000000	0.85682	D	0.000000	T	0.59307	0.2184	H	0.95114	3.625	0.80722	D	1	P;D	0.57257	0.874;0.979	P;D	0.63283	0.824;0.913	T	0.71596	-0.4545	9	.	.	.	.	18.5999	0.91246	0.0:0.0:1.0:0.0	.	140;547	B4DFP0;Q9ULB4	.;CADH9_HUMAN	V	547	ENSP00000231021:A547V	.	A	-	2	0	CDH9	26921722	1.000000	0.71417	1.000000	0.80357	0.604000	0.37047	4.552000	0.60747	2.740000	0.93945	0.563000	0.77884	GCA	CDH9-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000207352.1	178.144671	KEEP		-	178.152074	0.491525	58	60	---	---	---	---	0	0	0	0	0	140	75	83	0	140	2	1	1	71	248	0	140	75	83	0	140	2	TP
ANKHD1	54882	broad.mit.edu	37	5	139889605	139889605	+	Splice_Site	SNP	G	G	A			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr5:139889605G>A	ENST00000297183.6	+	22	4067	c.3941_splice	c.e22-1	p.G1315_splice	ANKHD1-EIF4EBP3_ENST00000532219.1_Splice_Site_p.G1315_splice|ANKHD1_ENST00000360839.2_Splice_Site_p.G1315_splice	NM_020690.5	NP_065741.3			ankyrin repeat and KH domain containing 1	NA		NA								breast(2)|endometrium(8)|kidney(6)|large_intestine(14)|lung(18)|ovary(5)|prostate(2)|skin(3)|urinary_tract(2)	60			KIRC - Kidney renal clear cell carcinoma(527;0.00112)|Kidney(363;0.00191)			TGTTTACAGGGGAGCCCACAT	0.393	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													120	115	117	NA		NA	NA	5		NA											NA				139889605		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000131503	HGNC:24714	NM_017747	Approved		NA		ENST00000297183.6	37	CCDS4224.1	.	.	.	.	.	.	.	.	.	.	G	19.14	3.770159	0.69992	.	.	ENSG00000131503;ENSG00000131503;ENSG00000131503;ENSG00000131503;ENSG00000131503;ENSG00000131503;ENSG00000131503;ENSG00000131503;ENSG00000254996	ENST00000360839;ENST00000422011;ENST00000297183;ENST00000253810;ENST00000310356;ENST00000235510;ENST00000421134;ENST00000412116;ENST00000532219	T;T;T;T;T	0.72051	-0.62;-0.62;-0.62;-0.62;-0.62	5.63	5.63	0.86233	Ankyrin repeat-containing domain (4);	0.058745	0.64402	D	0.000002	D	0.84696	0.5529	M	0.74467	2.265	0.80722	D	1	B;P;P;D;D	0.89917	0.193;0.532;0.587;1.0;1.0	B;B;P;D;D	0.77557	0.225;0.437;0.672;0.99;0.99	D	0.84599	0.0671	10	0.56958	D	0.05	.	20.0529	0.97634	0.0:0.0:1.0:0.0	.	526;1315;1334;1315;1315	E7ET58;Q8IWZ3-4;E9PDP5;Q8IWZ2;Q8IWZ3	.;.;.;.;ANKH1_HUMAN	R	1315;1348;1315;1315;849;526;1334;468;1315	ENSP00000354085:G1315R;ENSP00000297183:G1315R;ENSP00000394489:G1334R;ENSP00000405602:G468R;ENSP00000432016:G1315R	ENSP00000432016:G1315R	G	+	1	0	ANKHD1-EIF4EBP3;ANKHD1	139869789	1.000000	0.71417	1.000000	0.80357	0.456000	0.32438	7.928000	0.87587	2.814000	0.96858	0.591000	0.81541	GGA	ANKHD1-201	KNOWN	basic|exp_conf|CCDS	protein_coding	NA	protein_coding		108.776807	KEEP	Missense_Mutation	+	114.319413	0.286765	39	97	---	---	---	---	1	0.9992795	7	25	0	148	45	115	0	148	2	0	0	0	0	0	148	45	115	0	148	2	TP
PCDHGB3	0	broad.mit.edu	37	5	140751537	140751537	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr5:140751537C>T	ENST00000576222.1	+	1	1707	c.1576C>T	c.(1576-1578)Cgt>Tgt	p.R526C	PCDHGB2_ENST00000522605.1_Intron|PCDHGA1_ENST00000517417.1_Intron|PCDHGA6_ENST00000517434.1_5'Flank|PCDHGA2_ENST00000394576.2_Intron|PCDHGA5_ENST00000518069.1_Intron|PCDHGA3_ENST00000253812.6_Intron|PCDHGA4_ENST00000571252.1_Intron|PCDHGB1_ENST00000523390.1_Intron	NM_018924.2|NM_032097.1	NP_061747.1|NP_115268.1				NA		NA								endometrium(1)|kidney(1)|lung(3)	5			KIRC - Kidney renal clear cell carcinoma(527;0.00112)|Kidney(363;0.00191)			CGAGCAGCTGCGTGCCTTCGA	0.692	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													37	44	42	NA		NA	NA	5		NA											NA				140751537		2132	4233	6365	SO:0001583	missense								NA		ENST00000576222.1	37	CCDS58980.1																																																																																			PCDHGB3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000437094.1	22.12967	KEEP		+	33.769263	0.139785	13	80	---	---	---	---	1	1	6	332	0	58	17	86	0	58	2	0	0	0	0	0	58	17	86	0	58	2	TP
CAMK2A	815	broad.mit.edu	37	5	149602771	149602771	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr5:149602771C>T	ENST00000348628.6	-	17	1879	c.1214G>A	c.(1213-1215)cGg>cAg	p.R405Q	CAMK2A_ENST00000398376.3_Missense_Mutation_p.R416Q|CAMK2A_ENST00000351010.6_5'UTR	NM_015981.3|NM_171825.2	NP_057065.2|NP_741960.1	Q9UQM7	KCC2A_HUMAN	calcium/calmodulin-dependent protein kinase II alpha	405		NA			interferon-gamma-mediated signaling pathway|positive regulation of NF-kappaB transcription factor activity|synaptic transmission	cell junction|cytosol|endocytic vesicle membrane|nucleoplasm|presynaptic membrane	ATP binding|calmodulin binding|calmodulin-dependent protein kinase activity			cervix(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(6)|skin(1)|stomach(1)	15		all_hematologic(541;0.224)	KIRC - Kidney renal clear cell carcinoma(527;0.000785)|Kidney(363;0.00101)			CTTGCTGTTCCGGGACCACAC	0.612	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													57	65	62	NA		NA	NA	5		NA											NA				149602771		2201	4298	6499	SO:0001583	missense			ENSG00000070808	HGNC:1460	NM_015981	Approved	uc003lrt.2	NA	Q9UL21|Q9Y2H4|Q9Y352	ENST00000348628.6	37	CCDS43386.1	.	.	.	.	.	.	.	.	.	.	C	18.94	3.730158	0.69074	.	.	ENSG00000070808	ENST00000348628;ENST00000398376	T;T	0.42513	0.97;0.97	5.02	5.02	0.67125	Protein kinase-like domain (1);Calcium/calmodulin-dependent protein kinase II, association-domain (1);	0.081845	0.48767	U	0.000174	T	0.31796	0.0808	N	0.15975	0.35	0.37842	D	0.929091	B;B;B	0.26195	0.144;0.106;0.144	B;B;B	0.28011	0.041;0.085;0.041	T	0.26189	-1.0110	10	0.49607	T	0.09	.	18.4099	0.90548	0.0:1.0:0.0:0.0	.	405;416;405	Q9UQM7;A8K161;Q7LDD5	KCC2A_HUMAN;.;.	Q	405;416	ENSP00000261793:R405Q;ENSP00000381412:R416Q	ENSP00000261793:R405Q	R	-	2	0	CAMK2A	149582964	1.000000	0.71417	1.000000	0.80357	0.984000	0.73092	4.201000	0.58439	2.350000	0.79820	0.456000	0.33151	CGG	CAMK2A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000258869.2	-6.687466	KEEP		-	11.453932	0.056818	5	83	---	---	---	---	1	0.369507	2	20	0	47	5	94	0	47	2	0	0	0	0	0	47	5	94	0	47	2	TP
LARP1	23367	broad.mit.edu	37	5	154188110	154188110	+	Silent	SNP	G	G	A			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr5:154188110G>A	ENST00000336314.4	+	16	2583	c.2559G>A	c.(2557-2559)aaG>aaA	p.K853K		NM_015315.3	NP_056130.2	Q6PKG0	LARP1_HUMAN	La ribonucleoprotein domain family, member 1	930		NA					protein binding|RNA binding			breast(1)|endometrium(3)|kidney(2)|large_intestine(10)|lung(9)|ovary(3)|pancreas(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)	33	Renal(175;0.00488)	Medulloblastoma(196;0.0354)|all_neural(177;0.147)	KIRC - Kidney renal clear cell carcinoma(527;0.00112)			TCAACAAAAAGATGTATGAGG	0.532	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													77	75	76	NA		NA	NA	5		NA											NA				154188110		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000155506	HGNC:29531	NM_033551	Approved	uc003lvo.4	NA	O94836|Q8N4M2|Q8NB73|Q9UFD7	ENST00000336314.4	37	CCDS4328.1																																																																																			LARP1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000252509.1	93.7915	KEEP		+	103.642353	0.237179	37	119	---	---	---	---	1	0.9999866	22	39	0	89	43	143	0	89	2	0	0	0	0	0	89	43	143	0	89	2	TP
LARP1	23367	broad.mit.edu	37	5	154188112	154188112	+	Missense_Mutation	SNP	T	T	A			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr5:154188112T>A	ENST00000336314.4	+	16	2585	c.2561T>A	c.(2560-2562)aTg>aAg	p.M854K		NM_015315.3	NP_056130.2	Q6PKG0	LARP1_HUMAN	La ribonucleoprotein domain family, member 1	931		NA					protein binding|RNA binding			breast(1)|endometrium(3)|kidney(2)|large_intestine(10)|lung(9)|ovary(3)|pancreas(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)	33	Renal(175;0.00488)	Medulloblastoma(196;0.0354)|all_neural(177;0.147)	KIRC - Kidney renal clear cell carcinoma(527;0.00112)			AACAAAAAGATGTATGAGGAG	0.532	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													77	75	76	NA		NA	NA	5		NA											NA				154188112		2203	4300	6503	SO:0001583	missense			ENSG00000155506	HGNC:29531	NM_033551	Approved	uc003lvo.4	NA	O94836|Q8N4M2|Q8NB73|Q9UFD7	ENST00000336314.4	37	CCDS4328.1	.	.	.	.	.	.	.	.	.	.	T	33	5.236312	0.95240	.	.	ENSG00000155506	ENST00000336314	T	0.52526	0.66	5.83	5.83	0.93111	.	0.000000	0.85682	D	0.000000	T	0.74481	0.3722	M	0.91510	3.215	0.80722	D	1	P;D	0.62365	0.955;0.991	P;D	0.65573	0.774;0.936	T	0.81099	-0.1086	10	0.87932	D	0	-8.1169	16.1883	0.81967	0.0:0.0:0.0:1.0	.	931;854	Q6PKG0;Q6PKG0-3	LARP1_HUMAN;.	K	854	ENSP00000336721:M854K	ENSP00000336721:M854K	M	+	2	0	LARP1	154168305	1.000000	0.71417	1.000000	0.80357	0.993000	0.82548	7.862000	0.87013	2.231000	0.72958	0.454000	0.30748	ATG	LARP1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000252509.1	95.818339	KEEP		+	106.369583	0.229299	36	121	---	---	---	---	1	0.9999902	21	44	0	88	42	145	0	88	2	0	0	0	0	0	88	42	145	0	88	2	TP
GABRA6	2559	broad.mit.edu	37	5	161116737	161116737	+	Missense_Mutation	SNP	G	G	T	rs145469537		GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr5:161116737G>T	ENST00000523217.1	+	6	837	c.595G>T	c.(595-597)Gat>Tat	p.D199Y	GABRA6_ENST00000274545.5_Missense_Mutation_p.D209Y|RP11-348M17.2_ENST00000521984.1_RNA	NM_000811.2	NP_000802.2	Q16445	GBRA6_HUMAN	gamma-aminobutyric acid (GABA) A receptor, alpha 6	209		NA			gamma-aminobutyric acid signaling pathway	cell junction|chloride channel complex|integral to plasma membrane|postsynaptic membrane	benzodiazepine receptor activity|chloride channel activity	p.D209N(1)		breast(1)|central_nervous_system(2)|endometrium(6)|large_intestine(9)|liver(2)|lung(22)|ovary(7)|skin(6)|urinary_tract(2)	57	Renal(175;0.00259)	Medulloblastoma(196;0.0208)|all_neural(177;0.0672)	Kidney(164;7.83e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000525)		Alprazolam(DB00404)|Ethchlorvynol(DB00189)|Flunitrazepam(DB01544)|Flurazepam(DB00690)|Lorazepam(DB00186)|Meprobamate(DB00371)|Midazolam(DB00683)	TCTCCAGTATGATCTGATTGG	0.378	NA	NA								TCGA Ovarian(5;0.080)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				1	Substitution - Missense(1)	skin(1)											74	82	79	NA		NA	NA	5		NA											NA				161116737		2203	4298	6501	SO:0001583	missense			ENSG00000145863	HGNC:4080		Approved	uc003lyu.2	NA	A8K096|Q4VAV2	ENST00000523217.1	37		.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	G|G	22.4|22.4	4.280818|4.280818	0.80692|0.80692	.|.	.|.	ENSG00000145863|ENSG00000145863	ENST00000274545;ENST00000523217;ENST00000517823;ENST00000523691|ENST00000520000	T;T;T;T|.	0.78816|.	-1.21;-1.21;-1.21;-1.21|.	5.41|5.41	5.41|5.41	0.78517|0.78517	Neurotransmitter-gated ion-channel ligand-binding (3);|.	0.095949|.	0.64402|.	D|.	0.000001|.	T|T	0.76183|0.76183	0.3952|0.3952	M|M	0.72479|0.72479	2.2|2.2	0.80722|0.80722	D|D	1|1	D|.	0.89917|.	1.0|.	D|.	0.97110|.	1.0|.	T|T	0.75133|0.75133	-0.3425|-0.3425	10|5	0.46703|.	T|.	0.11|.	.|.	19.1903|19.1903	0.93663|0.93663	0.0:0.0:1.0:0.0|0.0:0.0:1.0:0.0	.|.	209|.	Q16445|.	GBRA6_HUMAN|.	Y|I	209;199;156;129|148	ENSP00000274545:D209Y;ENSP00000430527:D199Y;ENSP00000430212:D156Y;ENSP00000427989:D129Y|.	ENSP00000274545:D209Y|.	D|M	+|+	1|3	0|0	GABRA6|GABRA6	161049315|161049315	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.996000|0.996000	0.88848|0.88848	9.671000|9.671000	0.98627|0.98627	2.526000|2.526000	0.85167|0.85167	0.655000|0.655000	0.94253|0.94253	GAT|ATG	GABRA6-003	KNOWN	not_organism_supported|basic	protein_coding	NA	protein_coding	OTTHUMT00000374125.1	5.956395	KEEP		+	62.090966	0.084375	27	293	---	---	---	---	0	0	0	0	0	116	31	351	0	116	2	1	0.9999966	87	136	0	116	31	351	0	116	2	TP
EGFR	1956	broad.mit.edu	37	7	55233043	55233043	+	Missense_Mutation	SNP	G	G	T	rs139236063		GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr7:55233043G>T	ENST00000275493.2	+	15	1970	c.1793G>T	c.(1792-1794)gGa>gTa	p.G598V	EGFR_ENST00000442591.1_Missense_Mutation_p.G598V|EGFR_ENST00000344576.2_Missense_Mutation_p.G598V|EGFR_ENST00000342916.3_Missense_Mutation_p.G598V|EGFR_ENST00000454757.2_Missense_Mutation_p.G545V|EGFR_ENST00000455089.1_Missense_Mutation_p.G553V	NM_005228.3	NP_005219.2	P00533	EGFR_HUMAN	epidermal growth factor receptor	598		NA			activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A	basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex	actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity	p.G598V(15)		NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6)	14110	all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318)		GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607)		Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072)	TGCCCGGCAGGAGTCATGGGA	0.567	NA	8	"""A, O, Mis"""		"""glioma, NSCLC"""	NSCLC			Lung Cancer, Familial Clustering of	TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Dom	yes	Familial lung cancer	7	7p12.3-p12.1	1956	"""epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)"""		"""E, O"""	15	Substitution - Missense(15)	central_nervous_system(15)											96	84	88	NA		NA	NA	7		NA											NA				55233043		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	incl. Hereditary Lung cancer, Hereditary Non-Small Cell Lung cancer	ENSG00000146648	HGNC:3236	NM_005228	Approved	uc003tqk.3	NA	O00688|O00732|P06268|Q14225|Q68GS5|Q92795|Q9BZS2|Q9GZX1|Q9H2C9|Q9H3C9|Q9UMD7|Q9UMD8|Q9UMG5	ENST00000275493.2	37	CCDS5514.1	.	.	.	.	.	.	.	.	.	.	G	24.8	4.567929	0.86439	.	.	ENSG00000146648	ENST00000455089;ENST00000342916;ENST00000395504;ENST00000344576;ENST00000275493;ENST00000442591;ENST00000454757;ENST00000533450	T;T;T;T;T;T	0.39787	1.06;1.06;1.06;1.06;1.06;1.06	5.87	5.87	0.94306	Growth factor, receptor (1);	0.000000	0.85682	D	0.000000	T	0.75671	0.3881	H	0.94503	3.545	0.80722	D	1	D;D;D;D	0.89917	0.991;0.999;0.998;1.0	P;D;D;D	0.91635	0.729;0.924;0.977;0.999	T	0.81858	-0.0739	10	0.72032	D	0.01	.	18.7698	0.91887	0.0:0.0:1.0:0.0	.	553;598;598;598	Q504U8;P00533;P00533-3;P00533-4	.;EGFR_HUMAN;.;.	V	553;598;468;598;598;598;545;392	ENSP00000415559:G553V;ENSP00000342376:G598V;ENSP00000345973:G598V;ENSP00000275493:G598V;ENSP00000410031:G598V;ENSP00000395243:G545V	ENSP00000275493:G598V	G	+	2	0	EGFR	55200537	1.000000	0.71417	0.454000	0.27019	0.665000	0.39181	7.905000	0.87416	2.785000	0.95823	0.655000	0.94253	GGA	EGFR-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000251456.2	531.429983	KEEP		+	692.903393	0.17665	289	1347	---	---	---	---	1	1	50	323	1	149	333	1600	1	149	11	1	1	81	637	1	149	333	1600	1	149	17	TP
RPL7A	6130	broad.mit.edu	37	9	136217577	136217577	+	Silent	SNP	G	G	T			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr9:136217577G>T	ENST00000323345.6	+	6	651	c.621G>T	c.(619-621)gtG>gtT	p.V207V	MED22_ENST00000343730.5_5'Flank|MED22_ENST00000486395.1_5'Flank|RPL7A_ENST00000315731.4_Silent_p.V92V|MED22_ENST00000476080.1_5'Flank|MED22_ENST00000371999.1_5'Flank|MED22_ENST00000471524.1_5'Flank|SURF1_ENST00000495952.1_5'Flank|SNORD36B_ENST00000363961.1_RNA|SNORD36C_ENST00000516733.1_RNA|MED22_ENST00000344469.5_5'Flank|SNORD24_ENST00000383884.1_RNA|RPL7A_ENST00000463740.1_3'UTR|SNORD36A_ENST00000362874.1_RNA	NM_000972.2	NP_000963.1	P62424	RL7A_HUMAN	ribosomal protein L7a	207		NA			endocrine pancreas development|ribosome biogenesis|translational elongation|translational termination|viral transcription	cytosolic large ribosomal subunit|membrane fraction|polysomal ribosome	RNA binding|structural constituent of ribosome			cervix(1)|endometrium(1)|kidney(1)|lung(3)|upper_aerodigestive_tract(1)	7				OV - Ovarian serous cystadenocarcinoma(145;4.93e-07)|Epithelial(140;4.09e-06)|all cancers(34;3.78e-05)		TCACACAGGTGAACTCGTAAG	0.488	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													53	55	55	NA		NA	NA	9		NA											NA				136217577		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000148303	HGNC:10364	NM_000972	Approved	uc004cde.1	NA	P11518	ENST00000323345.6	37	CCDS6965.1																																																																																			RPL7A-009	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000054869.1	4.34974	KEEP		+	36.13922	0.086957	16	168	---	---	---	---	1	1	4	2190	0	62	20	203	0	62	2	0	0	0	0	0	62	20	203	0	62	2	TP
AS3MT	57412	broad.mit.edu	37	10	104638210	104638210	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr10:104638210C>T	ENST00000369880.3	+	8	762	c.685C>T	c.(685-687)Cgt>Tgt	p.R229C	C10ORF32_ENST00000299353.6_3'UTR	NM_020682.3	NP_065733.2	Q9HBK9	AS3MT_HUMAN	arsenic (+3 oxidation state) methyltransferase	229		NA			arsonoacetate metabolic process|toxin metabolic process	cytosol	arsenite methyltransferase activity|methylarsonite methyltransferase activity			large_intestine(1)|lung(6)	7		Colorectal(252;0.122)|all_hematologic(284;0.152)|Breast(234;0.198)		Epithelial(162;5.87e-09)|all cancers(201;1.58e-07)|BRCA - Breast invasive adenocarcinoma(275;0.223)		CTGCCCTCCACGTTTGGTCAC	0.408	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													182	174	177	NA		NA	NA	10		NA											NA				104638210		1887	4134	6021	SO:0001583	missense			ENSG00000214435	HGNC:17452	NM_020682	Approved	uc001kwk.3	NA	A6NP79|Q5PZ02	ENST00000369880.3	37	CCDS41567.1	.	.	.	.	.	.	.	.	.	.	C	21.2	4.116486	0.77323	.	.	ENSG00000214435	ENST00000369880	T	0.23147	1.92	5.48	4.57	0.56435	.	0.053428	0.64402	D	0.000001	T	0.49184	0.1542	M	0.84585	2.705	0.36784	D	0.884491	P;D;D	0.64830	0.939;0.994;0.994	P;P;P	0.58454	0.515;0.839;0.839	T	0.64639	-0.6360	9	0.56958	D	0.05	-15.267	13.531	0.61621	0.0:0.9218:0.0:0.0781	.	229;229;229	Q0VDK3;Q9HBK9;Q0VDK4	.;AS3MT_HUMAN;.	C	229	ENSP00000358896:R229C	ENSP00000358896:R229C	R	+	1	0	AS3MT	104628200	0.941000	0.31946	1.000000	0.80357	0.994000	0.84299	1.939000	0.40213	2.569000	0.86673	0.561000	0.74099	CGT	AS3MT-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000050107.1	304.539865	KEEP		+	304.837606	0.460465	99	116	---	---	---	---	1	0.999986	20	4	1	302	107	130	1	302	2	0	0	0	0	1	302	107	130	1	302	2	TP
PTPN11	5781	broad.mit.edu	37	12	112926910	112926910	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr12:112926910G>C	ENST00000351677.2	+	13	1728	c.1530G>C	c.(1528-1530)caG>caC	p.Q510H		NM_002834.3	NP_002825.3	Q06124	PTN11_HUMAN	protein tyrosine phosphatase, non-receptor type 11	514	Tyrosine-protein phosphatase.	NA	Q -> P (in LEOPARD1).|Q -> R (in NS1).		axon guidance|cell junction assembly|ephrin receptor signaling pathway|epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|interferon-gamma-mediated signaling pathway|leukocyte migration|platelet activation|regulation of cell adhesion mediated by integrin|regulation of interferon-gamma-mediated signaling pathway|regulation of type I interferon-mediated signaling pathway|T cell costimulation|type I interferon-mediated signaling pathway	cytosol	non-membrane spanning protein tyrosine phosphatase activity|protein binding			NS(1)|autonomic_ganglia(2)|breast(1)|central_nervous_system(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(406)|kidney(2)|large_intestine(6)|lung(16)|ovary(1)|skin(1)|soft_tissue(3)|stomach(3)	451						CAGAAGCACAGTACCGATTTA	0.493	NA	NA	Mis		"""JMML, AML, MDS"""		Noonan Syndrome		Noonan syndrome					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		12	12q24.1	5781	"""protein tyrosine phosphatase, non-receptor type 11"""	yes	L	0													182	171	174	NA		NA	NA	12		NA											NA				112926910		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Male Turner syndrome, Pterygium Colli syndrome, incl. Noonan-like/Multiple Giant Cell Lesion syndrome; Noonan s. with multiple lentigines/LEOPARD syndrome	ENSG00000179295	HGNC:9644		Approved	uc001ttx.3	NA	A8K1D9|Q96HD7	ENST00000351677.2	37	CCDS9163.1	.	.	.	.	.	.	.	.	.	.	G	20.7	4.041522	0.75732	.	.	ENSG00000179295	ENST00000351677	D	0.99677	-6.37	5.13	2.29	0.28610	.	0.000000	0.85682	D	0.000000	D	0.99697	0.9885	M	0.93375	3.41	0.80722	D	1	D	0.89917	1.0	D	0.87578	0.998	D	0.99056	1.0829	10	0.87932	D	0	.	9.2895	0.37778	0.2656:0.0:0.7344:0.0	.	510	Q06124-2	.	H	510	ENSP00000340944:Q510H	ENSP00000340944:Q510H	Q	+	3	2	PTPN11	111411293	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	3.583000	0.53928	0.278000	0.22164	0.650000	0.86243	CAG	PTPN11-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000259496.2	778.62602	KEEP		+	888.641313	0.207493	288	1100	---	---	---	---	1	1	51	91	0	274	365	1469	0	274	2	0	0	0	0	0	274	365	1469	0	274	2	TP
SYNE2	23224	broad.mit.edu	37	14	64686074	64686074	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr14:64686074G>A	ENST00000357395.3	+	110	20036	c.8892G>A	c.(8890-8892)atG>atA	p.M2964I	SYNE2_ENST00000555022.1_Missense_Mutation_p.M457I|SYNE2_ENST00000555002.1_Missense_Mutation_p.M3236I|SYNE2_ENST00000554584.1_Missense_Mutation_p.M6495I|SYNE2_ENST00000441438.2_Missense_Mutation_p.M110I|SYNE2_ENST00000554805.1_Missense_Mutation_p.M362I|SYNE2_ENST00000358025.3_Missense_Mutation_p.M6602I|ESR2_ENST00000542956.1_Intron|SYNE2_ENST00000344113.4_Missense_Mutation_p.M6579I|SYNE2_ENST00000458046.2_Missense_Mutation_p.M236I|SYNE2_ENST00000394768.2_Missense_Mutation_p.M2964I			Q8WXH0	SYNE2_HUMAN	spectrin repeat containing, nuclear envelope 2	6579		NA			centrosome localization|cytoskeletal anchoring at nuclear membrane|nuclear migration along microfilament|positive regulation of cell migration	cytoskeleton|filopodium membrane|focal adhesion|integral to membrane|lamellipodium membrane|mitochondrial part|nuclear outer membrane|nucleoplasm|sarcoplasmic reticulum membrane|SUN-KASH complex|Z disc	actin binding|protein binding			NS(5)|breast(17)|central_nervous_system(3)|cervix(8)|endometrium(17)|haematopoietic_and_lymphoid_tissue(2)|kidney(21)|large_intestine(34)|lung(75)|ovary(10)|pancreas(2)|prostate(8)|skin(8)|stomach(1)|upper_aerodigestive_tract(9)|urinary_tract(4)	224				all cancers(60;0.00153)|OV - Ovarian serous cystadenocarcinoma(108;0.00444)|BRCA - Breast invasive adenocarcinoma(234;0.0681)		TGTTAAAGATGGCAAAGCCTC	0.433	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													84	82	83	NA		NA	NA	14		NA											NA				64686074		2203	4300	6503	SO:0001583	missense			ENSG00000054654	HGNC:17084	NM_182914	Approved	uc001xgl.3	NA	Q540G1|Q8N1S3|Q8NF49|Q8TER7|Q8WWW3|Q8WWW4|Q8WWW5|Q8WXH1|Q9NU50|Q9UFQ4|Q9Y2L4|Q9Y4R1	ENST00000357395.3	37		.	.	.	.	.	.	.	.	.	.	G	6.477	0.456273	0.12283	.	.	ENSG00000054654	ENST00000358025;ENST00000357395;ENST00000344113;ENST00000554584;ENST00000261678;ENST00000555002;ENST00000394768;ENST00000555022;ENST00000554805;ENST00000458046;ENST00000441438	T;T;T;T;T;T;T;T;T;T	0.48836	0.8;0.8;0.8;0.8;0.8;0.8;0.8;0.8;0.8;0.8	5.53	1.64	0.23874	.	1.185320	0.06194	N	0.681828	T	0.37073	0.0990	L	0.29908	0.895	0.09310	N	0.999995	B;B;B;B;B;B;B;B	0.24576	0.036;0.008;0.106;0.029;0.01;0.024;0.018;0.029	B;B;B;B;B;B;B;B	0.22880	0.033;0.004;0.042;0.019;0.007;0.013;0.007;0.019	T	0.29912	-0.9996	10	0.36615	T	0.2	.	9.5329	0.39205	0.4181:0.0:0.5819:0.0	.	236;2964;110;236;967;6495;6579;6602	B4DND7;Q8WXH0-7;Q8WXH0-6;Q8WXH0-5;Q7Z362;G3V5X4;Q8WXH0;Q8WXH0-2	.;.;.;.;.;.;SYNE2_HUMAN;.	I	6602;2964;6579;6495;6501;3236;2964;457;362;236;110	ENSP00000350719:M6602I;ENSP00000349969:M2964I;ENSP00000341781:M6579I;ENSP00000452570:M6495I;ENSP00000450831:M3236I;ENSP00000378249:M2964I;ENSP00000451009:M457I;ENSP00000450605:M362I;ENSP00000391937:M236I;ENSP00000396794:M110I	ENSP00000261678:M6501I	M	+	3	0	SYNE2	63755827	0.001000	0.12720	0.018000	0.16275	0.388000	0.30384	0.690000	0.25451	0.287000	0.22375	-0.136000	0.14681	ATG	SYNE2-202	KNOWN	basic	protein_coding	NA	protein_coding		22.672456	KEEP		+	42.579535	0.120567	17	124	---	---	---	---	1	0.9921907	32	35	0	87	18	146	0	87	2	0	0	0	0	0	87	18	146	0	87	2	TP
FBXL16	146330	broad.mit.edu	37	16	745854	745854	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr16:745854C>T	ENST00000397621.1	-	3	1034	c.703G>A	c.(703-705)Ggg>Agg	p.G235R	FBXL16_ENST00000324361.5_Missense_Mutation_p.G235R|FBXL16_ENST00000562585.1_5'Flank|FBXL16_ENST00000562563.1_Missense_Mutation_p.G23R	NM_153350.3	NP_699181.2	Q8N461	FXL16_HUMAN	F-box and leucine-rich repeat protein 16	235		NA								endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|lung(3)|ovary(1)	10		Hepatocellular(780;0.0218)				GACCACAGCCCGGCCTCGGTG	0.672	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0													28	28	28	NA		NA	NA	16		NA											NA				745854		2199	4288	6487	SO:0001583	missense			ENSG00000127585	HGNC:14150	NM_153350	Approved	uc021taa.1	NA	D3DU60|Q2MHR2|Q96S14|Q9UJI0	ENST00000397621.1	37	CCDS10421.1	.	.	.	.	.	.	.	.	.	.	c	19.67	3.871664	0.72065	.	.	ENSG00000127585	ENST00000397621;ENST00000324361	T;T	0.18502	2.21;2.21	4.86	4.86	0.63082	.	0.000000	0.85682	D	0.000000	T	0.48277	0.1491	M	0.87547	2.89	0.80722	D	1	D	0.89917	1.0	D	0.81914	0.995	T	0.56878	-0.7906	10	0.87932	D	0	.	16.7252	0.85419	0.0:1.0:0.0:0.0	.	235	Q8N461	FXL16_HUMAN	R	235	ENSP00000380746:G235R;ENSP00000318674:G235R	ENSP00000318674:G235R	G	-	1	0	FBXL16	685855	1.000000	0.71417	0.793000	0.32043	0.960000	0.62799	4.721000	0.61951	2.529000	0.85273	0.561000	0.74099	GGG	FBXL16-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000206851.2	41.105609	KEEP		-	41.548265	0.666667	12	6	---	---	---	---	1	1	4	102	0	59	15	9	0	59	2	0	0	0	0	0	59	15	9	0	59	2	TP
EML2	24139	broad.mit.edu	37	19	46112931	46112931	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr19:46112931C>T	ENST00000536630.1	-	22	2519	c.2381G>A	c.(2380-2382)cGg>cAg	p.R794Q	EML2_ENST00000589876.1_Intron|EML2_ENST00000587152.1_Missense_Mutation_p.R848Q|EML2_ENST00000245925.3_Missense_Mutation_p.R647Q	NM_001193269.1	NP_001180198.1	O95834	EMAL2_HUMAN	echinoderm microtubule associated protein like 2	647		NA			sensory perception of sound|visual perception	cytoplasm|intracellular membrane-bounded organelle|microtubule|microtubule associated complex	catalytic activity|protein binding			NS(1)|breast(2)|cervix(1)|endometrium(1)|kidney(3)|large_intestine(8)|lung(13)|ovary(1)|urinary_tract(1)	31		Ovarian(192;0.179)|all_neural(266;0.224)		OV - Ovarian serous cystadenocarcinoma(262;0.00553)|GBM - Glioblastoma multiforme(486;0.131)|Epithelial(262;0.197)		TCAGACCACCCGCCACTGTAG	0.537	NA	NA											C	1	5e-04	NA	NA	2184	0.0017	1	,	,	NA	3e-04	NA	NA	NA	5e-04	1	LOWCOV,EXOME	NA	NA	7e-04	SNP						NA		NA				0													103	82	89	NA		NA	NA	19		NA											NA				46112931		2203	4300	6503	SO:0001583	missense				HGNC:18035	NM_012155	Approved	uc010xxm.2	NA	Q59EN8|Q8N5A2|Q9UG50	ENST00000536630.1	37	CCDS54280.1	1	4.578754578754579E-4	0	0.0	0	0.0	1	0.0017482517482517483	0	0.0	C	20.5	4.002238	0.74932	.	.	ENSG00000125746	ENST00000536630;ENST00000245925;ENST00000448055	T;T	0.29917	1.55;2.78	5.18	4.12	0.48240	WD40/YVTN repeat-like-containing domain (1);Soluble quinoprotein glucose/sorbosone dehydrogenase (1);WD40-repeat-containing domain (1);	0.372457	0.26951	N	0.021675	T	0.36963	0.0986	M	0.61387	1.9	0.26680	N	0.971551	D;D;D	0.61697	0.99;0.964;0.983	P;B;P	0.50896	0.567;0.232;0.653	T	0.17992	-1.0351	10	0.33141	T	0.24	-32.8719	9.8807	0.41231	0.0:0.9048:0.0:0.0952	.	813;794;647	B7Z3Q9;B7Z3I2;O95834	.;.;EMAL2_HUMAN	Q	794;647;805	ENSP00000442365:R794Q;ENSP00000245925:R647Q	ENSP00000245925:R647Q	R	-	2	0	EML2	50804771	0.998000	0.40836	1.000000	0.80357	0.917000	0.54804	1.150000	0.31639	2.700000	0.92200	0.462000	0.41574	CGG	EML2-005	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000459609.1	60.448893	KEEP		-	64.523986	0.2625	21	59	---	---	---	---	1	1	27	94	0	106	27	76	0	106	2	0	0	0	0	0	106	27	76	0	106	2	TP
SIRPA	140885	broad.mit.edu	37	20	1902301	1902301	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-2620-Tumor-SM-17P3Y	GBM-TCGA-19-2620-Normal-SM-1QXYM	g.chr20:1902301G>A	ENST00000358771.4	+	3	849	c.697G>A	c.(697-699)Gtc>Atc	p.V233I	SIRPA_ENST00000400068.3_Missense_Mutation_p.V233I|SIRPA_ENST00000356025.3_Missense_Mutation_p.V233I	NM_001040023.1	NP_001035112.1	P78324	SHPS1_HUMAN	signal-regulatory protein alpha	233	Ig-like C1-type 1.	NA			blood coagulation|cell adhesion|cell junction assembly|leukocyte migration	integral to membrane|plasma membrane	SH3 domain binding	p.V233I(1)		cervix(1)|endometrium(1)|kidney(1)|large_intestine(2)|lung(13)|ovary(1)|pancreas(1)|upper_aerodigestive_tract(1)	21				Colorectal(46;0.018)|READ - Rectum adenocarcinoma(1;0.0556)		GGTGGCCCACGTCACCTTGCA	0.617	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		GBM(155;1668 1920 5945 42733 48121)					NA		NA				1	Substitution - Missense(1)	lung(1)											67	60	62	NA		NA	NA	20		NA											NA				1902301		2203	4296	6499	SO:0001583	missense			ENSG00000198053	HGNC:9662	NM_080792	Approved	uc002wfr.3	NA	A2A2E1|A8K411|O00683|O43799|Q8N517|Q8TAL8|Q9H0Z2|Q9UDX2|Q9UIJ6|Q9Y4U9	ENST00000358771.4	37	CCDS13022.1	.	.	.	.	.	.	.	.	.	.	G	10.55	1.382458	0.24944	.	.	ENSG00000198053	ENST00000400068;ENST00000356025;ENST00000358771	T;T;T	0.02863	4.13;4.13;4.13	4.86	-7.7	0.01259	Immunoglobulin-like (1);Immunoglobulin C1-set (2);Immunoglobulin-like fold (1);	2.216010	0.01765	N	0.030825	T	0.02727	0.0082	L	0.27053	0.805	0.09310	N	1	B;B;B	0.14805	0.002;0.011;0.008	B;B;B	0.12156	0.002;0.007;0.006	T	0.30765	-0.9967	10	0.20519	T	0.43	.	13.8982	0.63785	0.7446:0.0:0.2554:0.0	.	213;233;233	B4DP97;P78324-2;P78324	.;.;SHPS1_HUMAN	I	233	ENSP00000382941:V233I;ENSP00000348307:V233I;ENSP00000351621:V233I	ENSP00000348307:V233I	V	+	1	0	SIRPA	1850301	0.000000	0.05858	0.000000	0.03702	0.766000	0.43426	-2.041000	0.01415	-1.573000	0.01659	-0.355000	0.07637	GTC	SIRPA-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000077568.2	9.234104	KEEP		+	16.055444	0.122449	6	43	---	---	---	---	1	0.9980872	4	86	0	72	7	47	0	72	2	0	0	0	0	0	72	7	47	0	72	2	TP
